Release date: 2017-03-21
Optical therapy technology has been widely used in various clinical disciplines due to its high energy, low power consumption, no pollution, and strong targeting, and has become an important treatment. Percutaneous non-invasive spectroscopy technology is the use of light and body tissue photophysical, photochemical, optomechanical, photomagnetic and other principles of action, the body to produce neurological intervention, immune regulation, tissue repair and other effects, is expected to replace drugs and traditional treatments for The treatment of clinical chronic diseases, immune diseases and malignant diseases is a safe, non-invasive, green treatment. However, the existing spectral therapy techniques generally have shortcomings such as low energy, shallow treatment depth, and slow effect, which limits the clinical research and application of the treatment method.
The Suzhou Medical Institute combines a strong optical foundation with biomedicine, using a number of patented technologies and special techniques to develop a special therapeutic spectrum that is consistent with the human body's light absorption curve. The therapeutic light has an ultra-wide spectrum from visible light to near-infrared, covering a variety of effective therapeutic bands, and can be used in various fields such as chronic inflammation, vascular and tissue regeneration, inflammatory pain, sports injuries, and treatment of malignant diseases. The researchers used patented technology to filter out the near-infrared B and C and part of the A-segment spectrum that are prone to skin thermal burns, effectively improving the safety of existing spectroscopy techniques, and thus increasing the therapeutic optical power to hundreds of watts. The penetration depth can reach more than 5cm under the skin, far exceeding the penetration depth of the existing phototherapy products, not only has a direct therapeutic effect on superficial lesions, but also acts on deep lesions such as abdominal cavity and pelvic cavity.
At present, based on this technology, the medical laboratory has developed medical equipment for hospital rehabilitation pain for the treatment of inflammation and chronic pain. It has passed the full performance test of Jiangsu Medical Device Testing Institute, completed the clinical trial and has declared the registration of medical device products. certificate. At the same time, the product prototype was carried out in the clinical bases of the First Affiliated Hospital of Jilin University, the Second Affiliated Hospital of Jilin University, the First Affiliated Hospital of Suzhou University, and the Guangzhou Zhenggu Hospital to carry out clinical treatment for herpes zoster, knee arthritis, postoperative pain and tumor treatment. Verification, the effect is significant. Follow-up will also develop a variety of user groups for community clinics, homes, fitness centers, and a series of special treatment products for special areas such as rehabilitation, animal rehabilitation, and cancer treatment, and push deep spectrum therapy technology to the clinic and truly serve the people. Enter an effective new treatment for chronic disease prevention and treatment.
Source: Chinese Academy of Sciences
Diagnostic reagents can be divided into two categories: in vivo diagnostic reagents and in vitro diagnostic reagents. It is mostly a reagent for detection by the reaction between antigen and antibody.
A: Classification of in vitro diagnostic reagents:
1. In vitro biodiagnostic reagents managed as drugs include:
1. Blood type and tissue type reagents;
2. Microbial antigen, antibody and nucleic acid detection reagents;
3. Tumor marker reagents;
4. Immunohistochemistry and human tissue cell reagents;
5. Human genetic testing reagents;
6. Biochips;
7. Allergy diagnostic reagents.
2. In vitro reagents managed as medical devices include:
1. Clinical basic test reagents;
2. Clinical chemistry reagents;
3. Blood gas and electrolyte determination reagents;
4. Vitamin determination reagents;
5. Cell histochemical stains;
6. Autoimmune diagnostic reagents;
7. Microbiological test reagents.
B: According to medical test items, clinical diagnostic reagents can be roughly divided into clinical chemical test reagents, immunology and
Serological testing reagents, hematological and cytogenetic testing reagents, microbiological testing reagents, body fluid excretion
Detection reagents, genetic diagnosis reagents, etc. Among them, the market share of clinical chemistry
The largest, close to 34%; followed by the immunology market, accounting for about 29%. Novel immunodiagnostic reagents and genetic diagnostic tests
The reagent was developed in the late 1980s, and it is the most common diagnostic reagent for all current diagnostic reagents, regardless of technology or market.
The fastest growing product.
Urine Rapid Test Kit,Rapid Test Kit 6-Panel,Toxoplasma rapid test kits,Fecal Occult Blood Test
Jilin Sinoscience Technology Co. LTD , https://www.jilinsinoscience.com